Companies: 10,795·Total market cap: $144.5T
CorMedix Inc.

CorMedix Inc.

CRMDNASDAQHealthcare● Active
$8.54
+$0.18(+2.15%)
Market Cap$669979149
P/E Ratio
52W High$17.43
52W Low$6.13

CorMedix Inc. (CRMD) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

crmd · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 8 Wall Street analysts in the past 3 months

SellBuy

Buy

8 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
0
Sell
0
Strong Sell
0
Total: 8 · Buy rate: 100.0%

12-Month Price Target

High

$16.00

Consensus

$14.00

+63.6% upside

Low

$13.00

Median: $13.5 · Last Close: $8.55

The CorMedix Inc. (CRMD) analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month CRMD price target is $14.00, representing +63.6% upside from the current price of $8.55.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $14 (63.6%)

Consensus Target

$14.00

63.6% upside

High Target

$16

87.0%

Low Target

$13

52.0%

Current Price

$8.55

as of today

Based on analyst price targets, the CRMD stock price prediction for the next 12 months ranges from $13 to $16. The consensus CRMD price forecast of $14.00 implies 63.6% upside from the current price of $8.55.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$8.752.26%

1-day model range: $8.71–$8.79. Peak: $8.79 (+2.26%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$11+28.9%
2028$13+49.3%
2029$14+62.4%
2030$15+70.2%
2031+74.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%7%14%
11Buy
1Neutral
2Sell
RSI (14)66.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · CRMD · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$8.37BUY
MA 10$8.39BUY
MA 20$8.09BUY
MA 50$7.67BUY
MA 100$7.38BUY
MA 200$9.38SELL
Current $CRMD · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.43BUY
EMA 10$8.34BUY
EMA 20$8.16BUY
EMA 50$7.85BUY
EMA 100$8.05BUY
EMA 200$8.74SELL
Current $CRMD · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
RBC Capital2026-04-28
Maintains
OutperformOutperform
Leerink Partners2026-04-28
Maintains
OutperformOutperform
Citizens2026-04-28
Maintains
Market OutperformMarket Outperform
D. Boral Capital2026-04-27
Maintains
BuyBuy
Needham2026-04-27
Maintains
BuyBuy
Needham2026-03-05
Maintains
BuyBuy
D. Boral Capital2026-02-11
Maintains
BuyBuy
HC Wainwright & Co.2026-01-23
Maintains
BuyBuy
RBC Capital2026-01-21
Maintains
OutperformOutperform
Needham2026-01-08
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on CorMedix Inc. (CRMD) stock. Of the recent 58 rating actions, 1 were upgrades and 1 were downgrades. 8 analysts currently cover CRMD.

Analyst Recommendation Trends

Buy ratings35↑ +2
Hold ratings00
Sell ratings00

CRMD analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 5 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$333M

↓ 3.7% YoY

Revenue Next Year

$287M

↓ 13.8% YoY

EPS This Year

$0.51

EPS Next Year

$0.13

↓ 74.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CRMD EPS of $0.51 for the current fiscal year, based on estimates from 4 analysts. The CRMD revenue forecast is $333M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CRMD stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CRMD price target is $14.00 (+63.6% upside), with an analyst consensus of Buy.

The CRMD short-term stock prediction for tomorrow is $8.75 (+2.26%). The CRMD stock price prediction for 2027 estimates an average of $11. The CRMD stock prediction for 2030 projects a range of $14–$15.

CorMedix Inc. trades on NASDAQ under the ticker CRMD. The CRMD stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CRMD forecast · 8 questions

According to 8 Wall Street analysts, the average 12-month CRMD price target is $14.00, with a high forecast of $16.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +63.6% potential upside from the current price of $8.55.

CRMD price targetWhat is CRMD price targetCRMD analyst price targetCRMD 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.